Subjects: MUTAGÊNICOS, MEDICAMENTO
ABNT
WAECHTER, Fernanda. Risk assessment of potentially mutagenic impurities in anti-hypertensive drug products approved in Brazil. 2021. Dissertação (Mestrado) – Universidade de São Paulo, São Paulo, 2021. Disponível em: https://www.teses.usp.br/teses/disponiveis/9/9143/tde-05082021-111631/. Acesso em: 09 out. 2024.APA
Waechter, F. (2021). Risk assessment of potentially mutagenic impurities in anti-hypertensive drug products approved in Brazil (Dissertação (Mestrado). Universidade de São Paulo, São Paulo. Recuperado de https://www.teses.usp.br/teses/disponiveis/9/9143/tde-05082021-111631/NLM
Waechter F. Risk assessment of potentially mutagenic impurities in anti-hypertensive drug products approved in Brazil [Internet]. 2021 ;[citado 2024 out. 09 ] Available from: https://www.teses.usp.br/teses/disponiveis/9/9143/tde-05082021-111631/Vancouver
Waechter F. Risk assessment of potentially mutagenic impurities in anti-hypertensive drug products approved in Brazil [Internet]. 2021 ;[citado 2024 out. 09 ] Available from: https://www.teses.usp.br/teses/disponiveis/9/9143/tde-05082021-111631/